Sanofi (NASDAQ:SNY) Releases Quarterly Earnings Results, Meets Expectations

Sanofi (NASDAQ:SNY) posted its quarterly earnings data on Thursday. The company reported $0.70 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.70, Zacks reports. Sanofi had a net margin of 9.96% and a return on equity of 27.45%.

Sanofi Stock Up 0.4 %

Shares of NASDAQ SNY opened at $54.34 on Friday. The stock has a market capitalization of $137.91 billion, a price-to-earnings ratio of 27.72, a price-to-earnings-growth ratio of 1.21 and a beta of 0.57. Sanofi has a 52 week low of $45.22 and a 52 week high of $58.97. The firm has a 50-day moving average price of $49.24 and a 200 day moving average price of $52.27. The company has a quick ratio of 0.65, a current ratio of 1.00 and a debt-to-equity ratio of 0.17.

Analyst Upgrades and Downgrades

SNY has been the topic of several analyst reports. Deutsche Bank Aktiengesellschaft raised shares of Sanofi from a “sell” rating to a “hold” rating in a report on Thursday. StockNews.com lowered Sanofi from a “buy” rating to a “hold” rating in a report on Thursday, December 12th. Finally, Sanford C. Bernstein upgraded Sanofi to a “strong-buy” rating in a research report on Thursday. Two analysts have rated the stock with a hold rating, one has given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $60.00.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.